223 related articles for article (PubMed ID: 28472346)
1. A c-Myb mutant causes deregulated differentiation due to impaired histone binding and abrogated pioneer factor function.
Fuglerud BM; Lemma RB; Wanichawan P; Sundaram AYM; Eskeland R; Gabrielsen OS
Nucleic Acids Res; 2017 Jul; 45(13):7681-7696. PubMed ID: 28472346
[TBL] [Abstract][Full Text] [Related]
2. The pioneer factor activity of c-Myb involves recruitment of p300 and induction of histone acetylation followed by acetylation-induced chromatin dissociation.
Fuglerud BM; Ledsaak M; Rogne M; Eskeland R; Gabrielsen OS
Epigenetics Chromatin; 2018 Jun; 11(1):35. PubMed ID: 29954426
[TBL] [Abstract][Full Text] [Related]
3. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
[TBL] [Abstract][Full Text] [Related]
4. c-Myb Binding Sites in Haematopoietic Chromatin Landscapes.
Bengtsen M; Klepper K; Gundersen S; Cuervo I; Drabløs F; Hovig E; Sandve GK; Gabrielsen OS; Eskeland R
PLoS One; 2015; 10(7):e0133280. PubMed ID: 26208222
[TBL] [Abstract][Full Text] [Related]
5. Chromatin occupancy and target genes of the haematopoietic master transcription factor MYB.
Lemma RB; Ledsaak M; Fuglerud BM; Sandve GK; Eskeland R; Gabrielsen OS
Sci Rep; 2021 Apr; 11(1):9008. PubMed ID: 33903675
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the transactivation domain (tAD) of the transcription factor c-Myb to assess recent models of tAD function.
Naes G; Storesund JO; Udayakumar PD; Ledsaak M; Gabrielsen OS
FEBS Open Bio; 2020 Nov; 10(11):2329-2342. PubMed ID: 32937031
[TBL] [Abstract][Full Text] [Related]
7. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability.
Saether T; Pattabiraman DR; Alm-Kristiansen AH; Vogt-Kielland LT; Gonda TJ; Gabrielsen OS
Oncogene; 2011 Jan; 30(2):212-22. PubMed ID: 20802522
[TBL] [Abstract][Full Text] [Related]
8. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.
Singh R; Winn LM
Mutat Res; 2008 Oct; 645(1-2):33-8. PubMed ID: 18778717
[TBL] [Abstract][Full Text] [Related]
9. Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb.
Zhao L; Glazov EA; Pattabiraman DR; Al-Owaidi F; Zhang P; Brown MA; Leo PJ; Gonda TJ
Nucleic Acids Res; 2011 Jun; 39(11):4664-79. PubMed ID: 21317192
[TBL] [Abstract][Full Text] [Related]
10. Regulated expression and role of c-Myb in the cardiovascular-directed differentiation of mouse embryonic stem cells.
Ishida M; El-Mounayri O; Kattman S; Zandstra P; Sakamoto H; Ogawa M; Keller G; Husain M
Circ Res; 2012 Jan; 110(2):253-64. PubMed ID: 22116818
[TBL] [Abstract][Full Text] [Related]
11. c-Myb regulates transcriptional activation of miR-143/145 in vascular smooth muscle cells.
Chandy M; Ishida M; Shikatani EA; El-Mounayri O; Park LC; Afroze T; Wang T; Marsden PA; Husain M
PLoS One; 2018; 13(8):e0202778. PubMed ID: 30169548
[TBL] [Abstract][Full Text] [Related]
12. c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus.
Kozuka T; Sugita M; Shetzline S; Gewirtz AM; Nakata Y
J Immunol; 2011 Dec; 187(11):5974-82. PubMed ID: 22039304
[TBL] [Abstract][Full Text] [Related]
13. PRMT4 is a novel coactivator of c-Myb-dependent transcription in haematopoietic cell lines.
Streubel G; Bouchard C; Berberich H; Zeller MS; Teichmann S; Adamkiewicz J; Müller R; Klempnauer KH; Bauer UM
PLoS Genet; 2013; 9(3):e1003343. PubMed ID: 23505388
[TBL] [Abstract][Full Text] [Related]
14. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
[TBL] [Abstract][Full Text] [Related]
15. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
Dahle Ø; Bakke O; Gabrielsen OS
Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
[TBL] [Abstract][Full Text] [Related]
16. The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells.
Zhao H; Kalota A; Jin S; Gewirtz AM
Blood; 2009 Jan; 113(3):505-16. PubMed ID: 18818396
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
[TBL] [Abstract][Full Text] [Related]
18. Three murine leukemia virus integration regions within 100 kilobases upstream of c-myb are proximal to the 5' regulatory region of the gene through DNA looping.
Zhang J; Markus J; Bies J; Paul T; Wolff L
J Virol; 2012 Oct; 86(19):10524-32. PubMed ID: 22811527
[TBL] [Abstract][Full Text] [Related]
19. A conserved patch of hydrophobic amino acids modulates Myb activity by mediating protein-protein interactions.
Dukare S; Klempnauer KH
Biochim Biophys Acta; 2016 Jul; 1859(7):914-21. PubMed ID: 27080133
[TBL] [Abstract][Full Text] [Related]
20. Substitution of Thr572 to Ala in mouse c-Myb attenuates progression of early erythroid differentiation.
Kitagawa K; Uchida C; Horiguchi R; Ohhata T; Sakai S; Niida H; Yasumoto S; Handa Y; Suzuki M; Hashimoto M; Tazawa T; Yokochi Y; Tsuji M; Kitagawa M
Sci Rep; 2020 Sep; 10(1):14381. PubMed ID: 32873855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
